Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Clinical Application Study of Obinutuzumab in Pediatric Refractory Nephrotic Syndrome

NCT07612592 is registered in ClinicalTrials.gov with Children's Hospital of Chongqing Medical University as lead sponsor.

NCT NCT07612592
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07612592 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Clinical Application Study of Obinutuzumab in Pediatric Refractory Nephrotic Syndrome
Lead sponsor
Children's Hospital of Chongqing Medical University
Phase
Observational
Overall status
Active, not recruiting
Start date
January 1, 2026
Completion date
December 1, 2026
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary nephrotic syndrome